WO2007001928A3 - Cibles pour l'inhibition de la replication du virus de l'hepatite c - Google Patents
Cibles pour l'inhibition de la replication du virus de l'hepatite c Download PDFInfo
- Publication number
- WO2007001928A3 WO2007001928A3 PCT/US2006/023646 US2006023646W WO2007001928A3 WO 2007001928 A3 WO2007001928 A3 WO 2007001928A3 US 2006023646 W US2006023646 W US 2006023646W WO 2007001928 A3 WO2007001928 A3 WO 2007001928A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibiting
- replication
- identified
- hcv replication
- hcv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
- C12N2330/31—Libraries, arrays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006262490A AU2006262490A1 (en) | 2005-06-22 | 2006-06-16 | Targets for inhibiting HCV replication |
CA002611528A CA2611528A1 (fr) | 2005-06-22 | 2006-06-16 | Cibles pour l'inhibition de la replication du virus de l'hepatite c |
EP06785052A EP1896619A2 (fr) | 2005-06-22 | 2006-06-16 | Cibles pour l'inhibition de la réplication du virus de l'hépatite c |
JP2008518260A JP2009501513A (ja) | 2005-06-22 | 2006-06-16 | Hcv複製阻害の標的 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69282105P | 2005-06-22 | 2005-06-22 | |
US60/692,821 | 2005-06-22 | ||
US71000605P | 2005-08-19 | 2005-08-19 | |
US60/710,006 | 2005-08-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007001928A2 WO2007001928A2 (fr) | 2007-01-04 |
WO2007001928A3 true WO2007001928A3 (fr) | 2011-05-26 |
Family
ID=37595694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/023646 WO2007001928A2 (fr) | 2005-06-22 | 2006-06-16 | Cibles pour l'inhibition de la replication du virus de l'hepatite c |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1896619A2 (fr) |
JP (1) | JP2009501513A (fr) |
AU (1) | AU2006262490A1 (fr) |
CA (1) | CA2611528A1 (fr) |
WO (1) | WO2007001928A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0814189A2 (pt) * | 2007-07-05 | 2015-03-03 | Novartis Ag | Ácido ribonucleico de filamento duplo, composição farmacêutica e seus usos, método para inibir a expressão de fosfatidilinositol 4-cinase, vetor e uso de um composto que seletivamente inibe a atividade da fosfatidilinositol 4-cinase. |
US8563730B2 (en) | 2008-05-16 | 2013-10-22 | Takeda San Diego, Inc. | Pyrazole and fused pyrazole glucokinase activators |
US20100183704A1 (en) * | 2008-09-25 | 2010-07-22 | Novartis Ag | dsRNA FOR TREATING VIRAL INFECTION |
WO2010137570A1 (fr) * | 2009-05-29 | 2010-12-02 | 学校法人慶應義塾 | Agent antiviral ou agent anticancéreux |
WO2021143932A1 (fr) * | 2020-01-19 | 2021-07-22 | 北京生命科学研究所 | Facteur hôte spécifique de l'infection par le virus de l'hépatite b et son utilisation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101874A1 (en) * | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
US20050101581A1 (en) * | 2002-08-28 | 2005-05-12 | Reading Christopher L. | Therapeutic treatment methods 2 |
-
2006
- 2006-06-16 AU AU2006262490A patent/AU2006262490A1/en not_active Abandoned
- 2006-06-16 CA CA002611528A patent/CA2611528A1/fr not_active Abandoned
- 2006-06-16 JP JP2008518260A patent/JP2009501513A/ja not_active Withdrawn
- 2006-06-16 EP EP06785052A patent/EP1896619A2/fr not_active Withdrawn
- 2006-06-16 WO PCT/US2006/023646 patent/WO2007001928A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101874A1 (en) * | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
US20050101581A1 (en) * | 2002-08-28 | 2005-05-12 | Reading Christopher L. | Therapeutic treatment methods 2 |
Non-Patent Citations (5)
Title |
---|
"PI4KA-HUMAN. Uniprotein", 10 May 2005 (2005-05-10), Retrieved from the Internet <URL:httpJ/www.uniprot.org/uniproUP42356.bctTversion=40> [retrieved on 20090720] * |
AZA-BLANC ET AL.: "Identification of modulators of TRAIL-Induced Apoptosis via RNAI-based Phenotypic Screening", MOL. CELL., vol. 12, no. 3, September 2003 (2003-09-01), pages 627 - 637 * |
KIM ET AL.: "Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.", J. BIOL. CHEM., vol. 279, no. 48, 26 November 2004 (2004-11-26), pages 50031 - 50041 * |
MAZZOCCA ET AL.: "Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.", J. BIOL. CHEM., vol. 280, no. 12, 25 March 2005 (2005-03-25), pages 11329 - 11339 * |
SCHMID-ANTOMARCH.: "HIV Induces activation of phosphatidyllnositol4-klnase and mitogen- activated protein kinase by interacting with T cell CD4 surface molecules.", EUR. J. IMMUNOL., vol. 26, 1996, pages 717 - 720 * |
Also Published As
Publication number | Publication date |
---|---|
AU2006262490A1 (en) | 2007-01-04 |
EP1896619A2 (fr) | 2008-03-12 |
CA2611528A1 (fr) | 2007-01-04 |
JP2009501513A (ja) | 2009-01-22 |
WO2007001928A2 (fr) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eiermann et al. | Dance with the devil: stress granules and signaling in antiviral responses | |
Panas et al. | Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection | |
WO2007002008A3 (fr) | Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines | |
JP2018082709A5 (fr) | ||
WO2010057203A3 (fr) | Particules de hdl pour administration d'acides nucléiques | |
WO2007110231A3 (fr) | POLYPEPTIDES D'INTERFÉRON-β (IFN-β) MODIFIÉS | |
WO2008140621A3 (fr) | Virus oncolytiques transgéniques et leurs utilisations | |
WO2003080807A3 (fr) | Compositions et methodes destinees a supprimer l'expression de genes eucaryotes | |
WO2008051928A3 (fr) | Amplification ciblée d'un génome entier d'acides nucléiques | |
EP4342987A3 (fr) | Composition pour cliver un adn cible comprenant un arn guide spécifique pour l'adn cible et un acide nucléique codant pour une protéine cas ou une protéine cas, et utilisation associée | |
BRPI0820647A2 (pt) | Polipeptídeo isolado, polinucleotídeo isolado, construção de ácido nucleico, célula hospedeira recombinante, métodos para produzir o polipeptídeo e um mutante de uma célula percursora, célula mutante, planta transgênica, parte de planta ou célula de planta, molécula de rna inibidora de filamento duplo, e, métodos para inibir a expressão de um polipeptídeo um uma célula e para produzir uma proteína e para degradar um xilano | |
EA201291024A1 (ru) | Композиции эндорибонуклеаз и способы их использования | |
WO2007124327A3 (fr) | Méthodes et compositions d'expression d'arn viral sens négatif dans des cellules canines | |
EP3418386A3 (fr) | Compositions et méthodes permettant d'inhiber l'expression d'un gène du virus de l'hépatite b | |
WO2004035765A3 (fr) | Structures et constructions d'arn a double brin et procedes pour leur generation et leur utilisation | |
WO2008145400A3 (fr) | Protéine structurale mutée d'un parvovirus | |
EP2274442A4 (fr) | Séquences consensus de protéines du virus chikungunya, molécules d acide nucléique codant pour celles-ci, et compositions et procédés d utilisation de celles-ci | |
WO2007097820A3 (fr) | Produits de gène viral et méthodes de vaccination pour prévenir des maladies virales associées | |
WO2009131919A3 (fr) | Polymérases pour incorporer des nucléotides modifiés | |
WO2002008286A3 (fr) | Code de reconnaissance pour domaines en doigt de zinc et ses utilisations | |
WO2010107739A3 (fr) | Méthodes et compositions pour traiter l'infection par un virus de la famille des flaviviridae | |
WO2007001928A3 (fr) | Cibles pour l'inhibition de la replication du virus de l'hepatite c | |
WO2005097205A3 (fr) | Micro-arn de virus a adn et procedes d'inhibition associes | |
WO2005118813A3 (fr) | Acides nucleiques, polypeptides, methodes d'expression, et compositions immunogenes associees a la proteine spike du coronavirus sras | |
WO2010042749A3 (fr) | Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006785052 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2611528 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006262490 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2008518260 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006262490 Country of ref document: AU Date of ref document: 20060616 Kind code of ref document: A |